Markets VideosWockhardt Decides To Exit US Generic Pharma Segment
ADVERTISEMENT

Wockhardt Decides To Exit US Generic Pharma Segment

14 Jul 2025, 11:02 PM IST i
NDTV Profit
NDTV Profit

Wockhardt has initiated strategic realignment of US operations to focus on innovative portfolio. The company has filed for voluntary liquidation of its US arms Morton Grove Pharma and Wockhardt USA.

Wockhardt Decides To Exit US Generic Pharma Segment
Wockhardt Decides To Exit US Generic Pharma Segment
Jul 14, 2025
VIP Industries' Next-Gen Won't Take Over, Says Chairman Dilip Piramal
VIP Industries' Next-Gen Won't Take Over, Says Chairman Dilip Piramal
Jul 14, 2025
RBI's Push Liquidity To Reflect Positively On Bank Earnings, Says Vikas Khemani
RBI's Push Liquidity To Reflect Positively On Bank Earnings, Says Vikas Khemani
Jul 14, 2025
View All